ClinicalTrials.gg
Not yet recruitingNCT07950696Cog-RTPUpdated Nov 20, 2026

Cognitive Function in Athletes Cleared for Return-to-Play After Sport-Related Concussion

An interventional study of Exercise in Concussion, Mild Traumatic Brain Injury, sponsored by Baylor Research Institute. Not yet recruiting at 1 site in United States. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Baylor Research Institute · Not applicable, Interventional, and Screening

How we know

Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
12 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 420 studies in Brain Concussion with a site in United States — 102 open to participants now, 123 under way, 5 of them phase 3. Brain Concussion · United States.

Planned enrollment
229th of 323
30 · median 60
Started
2027
with 3 others
No phase
265 of 420
63 open now
Primary completion
2029-09
later than 112 of 122 live
Registered
417th of 420
by date

Among the 420 studies in Brain Concussion with a site in United States, this one is the 229th largest by planned enrollment of the 323 interventional ones that give a count, is one of 4 that started in 2027, is one of 265 with no phase, reaches primary completion later than 112 of the 122 other live ones, and was the 417th registered.

Brain Concussion

641 studies on the registry are indexed under Brain Concussion; 167 are open to participants now.

Browse Brain Concussion studies →

Open to participants now

102 of the 420 studies in Brain Concussion with a site in United States are open now. Recruiting first, the newest first:

97 more — sign in →

All 102 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 114 Brain Concussion studies recruiting now, 34 (30%) set no upper age limit and 73 (64%) stop at 75 or younger; 24 take children under 18; 38 take healthy volunteers.

This study: 12 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 420 studies in Brain Concussion with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether a brief, objective cognitive assessment can detect exercise-induced changes in cognitive performance in adolescent athletes who have been medically cleared for return-to-play following sport-related concussion.

03

Conditions studied

  • Concussion, Mild Traumatic Brain Injury

Browse trials for

Keywords

  • concussion
  • mTBI
  • pediatric
04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 12-18 years old
  • Actively engaged in organized sports activities within the past 12 months
  • Completed RTP (Return-to-Play) testing within the past 30 days

Exclusion criteria

Exclusion Criteria:

  • History of ocular or muscular spasms
  • History of epileptic seizures
  • History of fainting or loss of consciousness triggered by flashes of light, patterns, or exposure to infrared light sources (e.g., eye tracker)
  • History of eye surgery and lenses implanted with different prescriptions in each eye
  • History of ptosis (drooping eyelids)
  • Taking medications that cause pupil dilation
  • Active concussion symptoms
  • Cardiovascular, respiratory, or neurological conditions contraindicating exertion
  • Orthopedic or neurologic, or other limitations
  • History of moderate or severe traumatic brain injury (GCS ≤12)
  • Uncontrolled asthma
  • Limited English proficiency
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Adolescents following medical clearance from concussion

    Other: Exercise

Interventions

  • OtherExercise

    Participants will undergo a supervised, 30-minute, moderate-intensity, bodyweight workout with a warm-up and a cool down.

06

What researchers measure

Primary outcomes

  1. Cognitive performance

    Cognitive performance measured before and immediately after standardized exercise during a single study visit. Cognitive domains assessed include Processing Speed, Executive Function, Working Memory, Short-Term Memory, Sustained Attention, Selective Attention, and Spatial Perception.

    Time frame: Baseline (pre-exercise) and immediately post-exercise during the single study visit

Secondary outcomes

  1. Rivermead Post Concussion Questionnaire 3 (RPQ-3)

    The RPQ-3 assesses the severity of three post-concussion symptoms: headache, dizziness, and nausea. Each item is scored on a scale of 0-4, with a total score ranging from 0 to 12. Higher scores indicate greater post-concussion symptom severity (worse outcomes).

    Time frame: baseline, pre-intervention

  2. Pediatric Quality of Life Inventory Short Form 15 (PedsQL 4.0 SF-15)

    The PedsQL 4.0 SF-15 assesses health-related quality of life in children and adolescents across four domains: physical functioning, emotional functioning, social functioning, and school functioning. The 15 items are rated on a 5-point Likert scale (0-4) and reverse-scored and linearly transformed to a 0-100 scale. The total score ranges from 0 to 100, with higher scores indicating better health-related quality of life (better outcomes).

    Time frame: baseline, pre-intervention

  3. Brief Pittsburgh Sleep Quality Index (B-PSQI)

    The B-PSQI assesses sleep quality over the past month across seven domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. The six items are scored on a scale of 0-3, with a total score ranging from 0 to 18. Higher scores indicate poorer sleep quality (worse outcomes).

    Time frame: baseline, pre-intervention

  4. Vestibular/Oculomotor Motor Screening (VOMS)

    The VOMS assesses vestibular and ocular motor symptom provocation following concussion. The assessment includes smooth pursuits, horizontal and vertical saccades, near point of convergence, vestibulo-ocular reflex (VOR), and visual motion sensitivity (VMS). Participants rate four symptoms (headache, dizziness, nausea, and fogginess) on a scale of 0-10 before and immediately after each task. The total symptom score ranges from 0 to 280, with higher scores indicating greater symptom severity (worse outcomes). Symptom provocation is also assessed by calculating the change in symptom ratings from baseline.

    Time frame: baseline, pre-intervention

07

Study locations

1 site
  • Baylor Scott & White Sports Therapy & Research at the Star
    Frisco, Texas 75034, United States
08

References and documents

Individual participant data

Plan to share: Yes — Aggregated and anonymized study findings will be reported in scientific publications. De-identified data will be shared with collaborators as specified in data use agreements after institutional review and approval.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2027; primary completion for Sep 2029, 23 months later.

Of 249 non-industry interventional studies with no phase under Brain Concussion, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 47. This study's planned 23 months is below that.

Counting every sponsor, half of 265 studies reached it within 28 months; a quarter within 19 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2026
First posted
Nov 20, 2026
StartEst.
Oct 30, 2027
Primary completionEst.
Sep 30, 2029
CompletionEst.
Dec 1, 2029
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07950696
Responsible party
Kayla Covert (Research Scientist 2, Baylor Research Institute) — Principal investigator
First posted
Nov 20, 2026
Start date
Oct 30, 2027 (estimated)
Primary completion
Sep 30, 2029 (estimated)
Completion
Dec 1, 2029 (estimated)
Last update
Nov 20, 2026

Study contacts

Kayla Covert, DPT
Contact
Kayla.Covert@BSWHealth.org
2146031527

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion